Macrophage-stimulating protein cooperates with erythropoietin to induce colony formation and MAP kinase activation in primary erythroid progenitor cells

Journal of Hematotherapy and Stem Cell Research

Volumn 12, Issue 2, 2003, Pages 165-177

  Teal, Hami E ^a   Craici, Anamaria ^a   Paulson, Robert F ^a   Correll, Pamela H ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Department of Veterinary Science ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ERYTHROPOIETIN; MACROPHAGE ACTIVATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; ENZYME ACTIVATION; ERYTHROID CELL; FRIEND LEUKEMIA VIRUS; GENE LOCUS; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; HEPATOCYTE GROWTH FACTOR; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 0038076500     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581603321628313     Document Type: Article

References (46)

1. Constantinescu SN, S Ghaffari and HF Lodish. (1999). The Erythropoietin receptor: structure, activation and intracellular signal transduction. Trends Endocrinol Metab 10:18-23.
2. Watowich SS. (1999). Activation of erythropoietin signaling by receptor dimerization. Int J Biochem Cell Biol 31:1075-1088.
3. Witthuhn BA, FW Quelle, O Silvennoinen, T Yi, B Tang, O Miura and JN Ihle. (1993). JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236.
4. Wu H, X Liu, R Jaenisch and HF Lodish. (1995). Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-67.
5. Neubauer H, A Cumano, M Muller, H Wu, U Huffstadt and K Pfeffer. (1998). Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93:397-409.
6. Parganas E, D Wang, D Stravopodis, DJ Topham, JC Marine, S Teglund, EF Vanin, S Bodner, OR Colamonici, JM van Deursen, G Grosveld and JN Ihle. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385-395.
7. Socolovsky M, H Nam, MD Fleming, VH Haase, C Brugnara and HF Lodish. (2001). Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98:3261-3273.
8. Russell ES. (1979). Hereditary anemias of the mouse: a review for geneticists. Adv Genet 20:357-459.
9. Iwama A, K Okano, T Sudo, Y Matsuda and T Suda. (1994). Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83:3160-3169.
10. Leonard EJ and AH Skeel. (1978). Isolation of macrophage stimulating protein (MSP) from human serum. Exp Cell Res 114:117-126.
11. Peace BE, MJ Hughes, SJ Degen and SE Waltz. (2001). Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 20:6142-6151.
12. Wang MH, FA Montero-Julian, I Dauny and EJ Leonard. (1996). Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 13:2167-2175.
13. Tamagnone L and PM Comoglio. (1997). Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine Growth Factor Rev 8:129-142.
14. Correll PH, A Iwama, S Tondat, G Mayrhofer, T Suda and A Bernstein. (1997). Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct 1:69-83.
15. Sonnenberg E, D Meyer, KM Weidner and C Birchmeier. (1993). Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123:223-235.
16. Medico E, AM Mongiovi, J Huff, MA Jelinek, A Follenzi, G Gaudino, JT Parsons and PM Comoglio. (1996). The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 7:495-504.
17. Banu N, DJ Price, R London, B Deng, M Mark, PJ Godowski and H Avraham. (1996). Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J Immunol 156:2933-2940.
18. Persons DA, RF Paulson, MR Loyd, MT Herley, SM Bodner, A Bernstein, PH Correll and PA Ney. (1999). Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nature Genet 23:159-165.
19. Mowat M, A Cheng, N Kimura, A Bernstein and S Benchimol. (1985). Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314:633-636.
20. Moreau-Gachelin F, A Tavitian and P Tambourin. (1988). Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331:277-280.
21. D'Andrea AD. (1992). The interaction of the erythropoietin receptor and gp55. Cancer Surv 15:19-36.
22. Li JP, AD D'Andrea, HF Lodish and D Baltimore. (1990). Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762-764.
23. Nishigaki K, D Thompson, C Hanson, T Yugawa and S Ruscetti. (2001). The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk. J Virol 75:7893-7903.
24. Finkelstein LD, PA Ney, QP Liu, RF Paulson and PH Correll. (2002). Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus. Oncogene 21:3562-3570.
25. Broxmeyer HE, S Cooper, ZH Li, L Lu, A Sarris, MH Wang, MS Chang, DB Donner and EJ Leonard. (1996). Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Ann Hematol 73:1-9.
26. Iwama A, N Yamaguchi and T Suda. (1996). STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J 15:5866-5875.
27. Chomczynski P and N Sacchi. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
28. Panzenbock B, P Bartunek, MY Mapara and M Zenke. (1998). Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 92:3658-3668.
29. Sui X, SB Krantz, M You and Z Zhao. (1998). Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood 92:1142-1149.
30. Kolonics A, A Apati, J Janossy, A Brozik, R Gati, A Schaefer and M Magocsi. (2001). Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells. Cell Signal 13:743-754.
31. Barnache S, P Mayeux, B Payrastre and F Moreau-Gachelin. (2001). Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts. Blood 98:2372-2381.
32. Muszynski KW, D Thompson, C Hanson, R Lyons, A Spadaccini and SK Ruscetti. (2000). Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP. J Virol 74:8444-8451.
33. Witt O, K Sand and A Pekrun. (2000). Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95:2391-2396.
34. Nagata Y and K Todokoro. (1999). Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94:853-863.
35. Nagata Y, N Takahashi, RJ Davis and K Todokoro. (1998). Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92:1859-1869.
36. Gong Q, AM Cheng, AM Akk, J Alberola-Ila, G Gong, T Pawson and AC Chan. (2001). Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nature Immunol 2:29-36.
37. Garcia-Guzman M, F Dolfi, K Zeh and K Vuori. (1999). Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1-Crk signaling complex formation. Oncogene 18:7775-7786.
38. Nguyen L, M Holgado-Madruga, C Maroun, ED Fixman, D Kamikura, T Fournier, A Charest, ML Tremblay, AJ Wong and M Park. (1997). Association of the multisubstrate docking protein Gabl with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J Biol Chem 272:20811-20819.
39. Weidner KM, S Di Cesare, M Sachs, V Brinkmann, J Behrens and W Birchmeier. (1996). Interaction between Gabl and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384:173-176.
40. Laffargue M, P Raynal, A Yart, C Peres, R Wetzker, S Roche, B Payrastre and H Chap. (1999). An epidermal growth factor receptor/Gab 1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid. J Biol Chem 274:32835-32841.
41. Sing GK, JR Keller, LR Ellingsworth and FW Ruscetti. (1988). Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72:1504-1511.
42. Hino M, A Tojo, K Miyazono, A Urabe and F. Takaku. (1988). Effects of type beta transforming growth factors on haematopoietic progenitor cells. Br J Haematol 70:143-147.
43. Krystal G, V Lam, W Dragowska, C Takahashi, J Appel, A Gontier, A Jenkins, H Lam, L Quon and P Lansdorp. (1994). Transforming growth factor beta 1 is an inducer of erythroid differentiation. J Exp Med 180:851-860.
44. Means RT, Jr. and SB Krantz. (1991). Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood 78:2564-2567.
45. Broxmeyer HE, DE Williams, L Lu, S Cooper, SL Anderson, GS Beyer, R Hoffman and BY Rubin. (1986). The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol 136:4487-4495.
46. + cells. Stem Cells 17:82-91.